BlackRock Institutional Trust’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.93M	Buy	380,570 +14,152	+4%	+$130K	﹤0.01%	2921
2016 Q3	$4.19M	Buy	366,418 +83,935	+30%	+$977K	﹤0.01%	2768
2016 Q2	$3.48M	Buy	282,483 +17,309	+7%	+$210K	﹤0.01%	2835
2016 Q1	$2.68M	Buy	265,174 +4,335	+2%	+$50.9K	﹤0.01%	2921
2015 Q4	$5.88M	Buy	260,839 +36,555	+16%	+$749K	﹤0.01%	2631
2015 Q3	$3.72M	Buy	224,284 +86,537	+63%	+$1.73M	﹤0.01%	2848
2015 Q2	$3.1M	Buy	137,747 +9,527	+7%	+$235K	﹤0.01%	2944
2015 Q1	$3.31M	Buy	128,220 +3,257	+3%	+$82.6K	﹤0.01%	2907
2014 Q4	$2.72M	Sell	124,963 -2,552	-2%	-$52.3K	﹤0.01%	2974
2014 Q3	$2.41M	Sell	127,515 -47,168	-27%	-$948K	﹤0.01%	2996
2014 Q2	$4.07M	Buy	174,683 +98,533	+129%	+$2.43M	﹤0.01%	2877
2014 Q1	$2.56M	Sell	76,150 -11,567	-13%	-$390K	﹤0.01%	3056
2013 Q4	$2.59M	Sell	87,717 -75,237	-46%	-$1.38M	﹤0.01%	3056
2013 Q3	$2.5M	Buy	+162,954	New	+$3.02M	﹤0.01%	3017